Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04151927 · ClinicalTrials.gov registry record · NA

Effects of Overnight Low Oxygen Exposure on Energy Balance

A NA study, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT04151927: Completed NA study, sponsored by Florida State University.

NCT04151927 is a NA study that has completed, run by Florida State University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04151927, a NA study, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This research study will evaluate changes in resting metabolic rate, appetite, and heart rate variability following overnight exposure (8 h/night) to normobaric hypoxia (NH) or normobaric normoxic (NN). In randomized order, participants will sleep one night in NH conditions (\~15% oxygen; achieved with nitrogen dilution, equivalent to \~8500 feet elevation) and another night in NN (control) conditions (\~20% oxygen; achieved with nitrogen dilution, equivalent to \~1000 feet elevation).

Primary Outcome

Resting metabolic rate will be accessed using indirect calorimetry (TrueOne 2400, Parvo Medics, Salt Lake City, UT) following 8 hours of overnight exposure to NH or NN.

Interventions

  • DEVICE Normobaric Hypoxia
  • DEVICE Normobaric Normoxia

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2019-12-11
Est. Completion 2021-10-02
Phase NA
Florida State University

219 total trials

What the finished NCT04151927 record still lists

NCT04151927 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Normobaric Hypoxia is the first listed.

NCT04151927 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04151927 about?

NCT04151927 is a clinical study titled "Effects of Overnight Low Oxygen Exposure on Energy Balance". This research study will evaluate changes in resting metabolic rate, appetite, and heart rate variability following overnight exposure (8 h/night) to normobaric hypoxia (NH) or normobaric normoxic (NN). In randomized order, participants will sleep one night in NH conditions (\~15% oxygen; achieved w...

What is the current status of trial NCT04151927?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-12-11. Estimated completion is 2021-10-02.

What interventions are being tested in trial NCT04151927?

The interventions under investigation include: Normobaric Hypoxia (DEVICE), Normobaric Normoxia (DEVICE).

Who is sponsoring clinical trial NCT04151927?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04151927's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04151927, the US trial registry maintained by the National Library of Medicine. NCT04151927 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.